143 related articles for article (PubMed ID: 30755817)
1. Dysregulated ENPP1 increases the malignancy of human lung cancer by inducing epithelial-mesenchymal transition phenotypes and stem cell features.
Hu M; Guo W; Liao Y; Xu D; Sun B; Song H; Wang T; Kuang Y; Jing B; Li K; Ling J; Yao F; Deng J
Am J Cancer Res; 2019; 9(1):134-144. PubMed ID: 30755817
[TBL] [Abstract][Full Text] [Related]
2. PM2.5 induces EMT and promotes CSC properties by activating Notch pathway in vivo and vitro.
Wang Y; Zhong Y; Hou T; Liao J; Zhang C; Sun C; Wang G
Ecotoxicol Environ Saf; 2019 Aug; 178():159-167. PubMed ID: 31002970
[TBL] [Abstract][Full Text] [Related]
3. The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells.
Yao X; Pham T; Temple B; Gray S; Cannon C; Chen R; Abdel-Mageed AB; Biliran H
PLoS One; 2016; 11(9):e0163228. PubMed ID: 27655370
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer.
Guo L; Sun C; Xu S; Xu Y; Dong Q; Zhang L; Li W; Wang X; Ying G; Guo F
Thorac Cancer; 2019 Feb; 10(2):128-136. PubMed ID: 30485693
[TBL] [Abstract][Full Text] [Related]
5. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
[TBL] [Abstract][Full Text] [Related]
6. Suppression of a cancer stem-like phenotype mediated by alpha-lipoic acid in human lung cancer cells through down-regulation of β-catenin and Oct-4.
Phiboonchaiyanan PP; Chanvorachote P
Cell Oncol (Dordr); 2017 Oct; 40(5):497-510. PubMed ID: 28677037
[TBL] [Abstract][Full Text] [Related]
7. The mechanisms for lung cancer risk of PM
Wei H; Liang F; Cheng W; Zhou R; Wu X; Feng Y; Wang Y
Environ Toxicol; 2017 Nov; 32(11):2341-2351. PubMed ID: 28846189
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism.
Phiboonchaiyanan PP; Kiratipaiboon C; Chanvorachote P
Chem Biol Interact; 2016 Apr; 250():1-11. PubMed ID: 26947806
[TBL] [Abstract][Full Text] [Related]
10. TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma.
Chen L; Li YC; Wu L; Yu GT; Zhang WF; Huang CF; Sun ZJ
J Cell Mol Med; 2018 Feb; 22(2):1337-1349. PubMed ID: 29193723
[TBL] [Abstract][Full Text] [Related]
11. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
12. TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.
de Aberasturi AL; Redrado M; Villalba M; Larzabal L; Pajares MJ; Garcia J; Evans SR; Garcia-Ros D; Bodegas ME; Lopez L; Montuenga L; Calvo A
Cancer Lett; 2016 Jan; 370(2):165-76. PubMed ID: 26546046
[TBL] [Abstract][Full Text] [Related]
13. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
[TBL] [Abstract][Full Text] [Related]
14. Resistin induces breast cancer cells epithelial to mesenchymal transition (EMT) and stemness through both adenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms.
Avtanski D; Garcia A; Caraballo B; Thangeswaran P; Marin S; Bianco J; Lavi A; Poretsky L
Cytokine; 2019 Aug; 120():155-164. PubMed ID: 31085453
[TBL] [Abstract][Full Text] [Related]
15. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin.
Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087
[TBL] [Abstract][Full Text] [Related]
16. Ti
Petpiroon N; Bhummaphan N; Soonnarong R; Chantarawong W; Maluangnont T; Pongrakhananon V; Chanvorachote P
Mol Pharmacol; 2019 Apr; 95(4):418-432. PubMed ID: 30737252
[TBL] [Abstract][Full Text] [Related]
17. Loss of PRRX1 induces epithelial-mesenchymal transition and cancer stem cell-like properties in A549 cells.
Zhu H; Sun G
Am J Transl Res; 2017; 9(4):1641-1650. PubMed ID: 28469771
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of cancer stem-like cells by the induction of epithelial-mesenchymal transition using lentiviral vector carrying E-cadherin shRNA in HT29 cell line.
Saltanatpour Z; Johari B; Alizadeh A; Lotfinia M; Majidzadeh-A K; Nikbin B; Kadivar M
J Cell Physiol; 2019 Dec; 234(12):22935-22946. PubMed ID: 31111504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
